Navigation Links
Improving Trial Design and Predictability in Rheumatoid Arthritis With Time Response Modeling, New Webinar July 23rd Hosted by Xtalks
Date:7/15/2014

Toronto, Canada (PRWEB) July 15, 2014

Given the high medical need in this category, there has been increasing interest in recent years on the part of biopharma in developing new, more effective compounds including biologics and biosimilars. With competition rising, it is critical to more efficiently design your clinical trials so as to accelerate cycle times and speed your products to patients in need.

Well designed time response models can be valuable tools in achieving these objectives. These models have been shown to be predictive of trial outcomes and can also be used to:

  •     Help design clinical trials
  •     Compare a new drug to existing therapies
  •     Examine the effects of time and endpoints on power and sample size
  •     Support endpoint selection

The webinar is intended to help drug developers:

  •     Optimize trial designs
  •     Review innovative trial design features and operating characteristics such as adaptive designs
  •     Investigate novel analysis methodologies to better achieve objectives
  •     Improve the probability of more efficiently and successfully developing new RA treatments

Join presenters from Quintiles, Dr. Russell Reeve, PhD, Senior Biostatistics Director, Center for Statistics in Drug Development, and Dr. Niti Goel, Senior Medical Director & Head, Rheumatology Center of Excellence, for an information session that will include a Q&A with the audience.

For more information or to register for this webinar, visit: Time Response Modeling in Rheumatoid Arthritis and Other Autoimmune Indications

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/sponsorship.ashx.

Contact:
Michelle Tran
Tel: +1 (416) 977-6555 ext 352
Email: mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2014/07/prweb12012695.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness"
2. IVF improving but fertility treatments keep multiple births high
3. Nanotubes can solder themselves, markedly improving device performance
4. FDA Guidance on Risk-based Monitoring While Improving Data Quality, New Life Science Webinar Hosted by Xtalks
5. Case Report Suggests Microbiome Therapeutics NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
6. SASB Releases Provisional Sustainability Accounting Standards for Health Care Industry, A Key Milestone in Improving Disclosure of Material Non-Financial Information
7. Patheon to Host Webinar on “Accelerating the Drug Development Trajectory by Improving Solubility of New Compounds”
8. Consumer Survey Indicates Mouth Guards Worsen TMJ Symptoms As Often As Significantly Improving Them – Holistic Technologies
9. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
10. Cord Blood America President Says Company Must Continue Improving Financial Results
11. Clearing the air: PNNL technology wins award for improving submarine air quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):